
# 🧪 Blood Test Report Analysis (Collected: 06/18/2020)

## ✅ Normal Findings

- **Glucose**: 89 mg/dL _(Normal)_
- **Hemoglobin A1c**: 5.0% _(Excellent)_
- **BUN, Creatinine, eGFR**: Kidney function normal
- **Electrolytes**: Sodium, Potassium, Chloride, CO2 — all normal
- **Calcium, Phosphorus**: Normal
- **LDH, AST**: Normal
- **Thyroid Panel**: TSH, T4, T3, Reverse T3, Antibodies — all normal
- **WBC, Platelets, Differential**: All within normal limits
- **Urinalysis**: All negative/normal
- **CRP (Cardiac)**: 0.70 mg/L — **Low cardiovascular risk**
- **Homocysteine**: 7.0 umol/L — Normal
- **Fibrinogen**: 249 mg/dL — Normal
- **Iron, TIBC, Saturation**: Normal

---

## ⚠️ Concerning or Flagged Values

| Test                      | Result     | Reference Range  | Concern                                 |
|---------------------------|------------|------------------|-----------------------------------------|
| **Magnesium**             | 2.4 High   | 1.6–2.3 mg/dL     | Mild elevation — usually benign         |
| **Bilirubin, Total**      | 1.7 High   | 0.0–1.2 mg/dL     | Mildly elevated — possible liver stress |
| **ALT (SGPT)**            | 79 High    | 0–44 IU/L         | Elevated liver enzyme                   |
| **Ferritin**              | 462 High   | 30–400 ng/mL      | Possible inflammation or iron overload  |
| **Cholesterol, Total**    | 204 High   | 100–199 mg/dL     | Slightly elevated                       |
| **Triglycerides**         | 335 High   | 0–149 mg/dL       | **Significantly high** — risk factor    |
| **HDL Cholesterol**       | 32 Low     | >39 mg/dL         | **Low** — not protective                |
| **VLDL Cholesterol**      | 67 High    | 5–40 mg/dL        | Correlates with high triglycerides      |
| **LDL Cholesterol**       | 105 High   | 0–99 mg/dL        | Borderline high                         |
| **Chol/HDL Ratio**        | 6.4 High   | Ideal < 5.0       | **Elevated risk** of heart disease      |
| **Vitamin D, 25-Hydroxy** | 17.5 Low   | 30–100 ng/mL      | **Deficient** — requires supplementation|
| **RBC Count**             | 6.07 High  | 4.14–5.80 x10⁶/uL | Mild polycythemia                       |
| **Hematocrit**            | 53.9 High  | 37.5–51.0%        | Matches high RBC — monitor hydration    |

---

## 🧠 Summary & Interpretation

### 🚨 Most Concerning Findings
- **Cardiovascular Risk**: High triglycerides, low HDL, high LDL, high total cholesterol and poor Chol/HDL ratio — **elevated atherosclerosis risk**.
- **Vitamin D Deficiency**: Below 20 ng/mL — **clinically deficient**.
- **Liver Stress**: Elevated ALT and bilirubin — may indicate fatty liver or metabolic stress.
- **Elevated Ferritin**: Could be inflammation or early iron overload.

### 🧐 Possible Contributors
- High carb/sugar intake
- Sedentary lifestyle
- Low sun exposure (vitamin D deficiency)
- Mild dehydration or sleep apnea (if polycythemia persists)

---

## 🧾 Recommendations

- **Vitamin D**: Supplement with 2000–5000 IU/day. Recheck in 3 months.
- **Lipid Panel**: 
  - Improve diet: low sugar, high-fiber, healthy fats
  - Exercise regularly
  - Discuss statin therapy with physician
- **Liver Panel**: Repeat ALT, AST, Bilirubin in 3–6 months
- **Ferritin Monitoring**: Recheck with full iron panel if symptoms present
- **Hydration Review**: Ensure adequate fluid intake if RBC/Hct stay elevated

---

💡 *"High triglycerides are like uninvited party crashers — they show up loud and dangerous."*


---

## Possible Sleep Apnea Inferred
**Possible sleep apnea** was inferred based on **elevated red blood cell markers**:
### **📈 Elevated Values:**
- **RBC Count**: 6.07 (High)
- **Hematocrit**: 53.9% (High)
- **Hemoglobin**: 17.6 (Upper-normal)

### **🧠 Why this matters:**
Sleep apnea causes **intermittent low oxygen levels (hypoxia)** during sleep. The body compensates by producing **more red blood cells** to carry oxygen more efficiently — this leads to
- **Polycythemia** (high RBC, Hct, Hb)
- Especially common in **undiagnosed or untreated sleep apnea**
### **🔍 Differential:**
- These results can also appear with:
    - **Dehydration**
    - **High altitude living**
    - **Testosterone use**
    - **Chronic lung disease**
    - **Smoking**
    - Or rarely, **blood disorders**

But when these are ruled out, and **lipid issues + liver stress + vitamin D deficiency** are also present (as in this case), sleep apnea becomes a **reasonable suspect** worth screening.

---

🛌 _“If you’re tired but your blood thinks you’re climbing Everest, it might be time for a sleep study.”_

---
## raw source report data
```text
Patient Details
Age(y/m/d): 039/01/28
Gender: M

Specimen Details

Date collected: 06/18/2020 0844 Local

Date received: 06/18/2020

Date entered: 06/18/2020

Date reported: 06/24/2020 0907 ET

Physician Details

Ordering: S HAGER

Referring:

ID: 1710128848

NPI: 1710128848

**General Comments & Additional Information**

**Alternate Control Number:** HA5S9Z929A2 **Total Volume:** Not Provided **Ordered Items**

CMP14+LP+TP+TSH+5AC+CBC/D/P...; Venipuncture

**Alternate Patient ID:** 90617

**Fasting:** Yes

TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB

CMP14+LP+TP+TSH+5AC+CBC/D/P...

Chemistries 01

Glucose 89 mg/dL 65-99 01

Hemoglobin A1c 5.0 % 4.8-5.6 01

Please Note: 01

Prediabetes: 5.7 - 6.4

Diabetes: >6.4

Glycemic control for adults with diabetes: <7.0

Uric Acid 6.7 mg/dL 3.7-8.6 01

Please Note: 01

Therapeutic target for gout patients: <6.0

BUN 17 mg/dL 6-20 01

Creatinine 1.15 mg/dL 0.76-1.27 01

eGFR If NonAfricn Am 80 mL/min/1.73 >59

eGFR If Africn Am 92 mL/min/1.73 >59

BUN/Creatinine Ratio 15 9-20

Sodium 139 mmol/L 134-144 01

Potassium 4.4 mmol/L 3.5-5.2 01

Chloride 102 mmol/L 96-106 01

Carbon Dioxide, Total 22 mmol/L 20-29 01

Calcium 9.8 mg/dL 8.7-10.2 01

Phosphorus 3.9 mg/dL 2.8-4.1 01

Magnesium 2.4 High mg/dL 1.6-2.3 01

Protein, Total 7.4 g/dL 6.0-8.5 01

Albumin 5.0 g/dL 4.0-5.0 01

Globulin, Total 2.4 g/dL 1.5-4.5

A/G Ratio 2.1 1.2-2.2

Bilirubin, Total 1.7 High mg/dL 0.0-1.2 01

Alkaline Phosphatase 82 IU/L 39-117 01

LDH 172 IU/L 121-224 01

Date Issued: 06/26/20 0924 ET FINAL REPORT This document contains private and confidential health information protected by state and federal law.

If you have received this document in error, please call 303-792-2600

Page 1 of 4

1995-2020 Laboratory Corporation of America® Holdings

All Rights Reserved - Enterprise Report Version:

1.00Patient Report

Patient:  Specimen ID: 170-612-0650-0

  Control ID: HA5S9Z929A2 Date collected: 06/18/2020 0844 Local

TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB

AST (SGOT) 39 IU/L 0-40 01

ALT (SGPT) 79 High IU/L 0-44 01

GGT 20 IU/L 0-65 01

Iron Bind.Cap.(TIBC) 289 ug/dL 250-450

UIBC 186 ug/dL 111-343 01

Iron 103 ug/dL 38-169 01

Iron Saturation 36 % 15-55

Ferritin, Serum 462 High ng/mL 30-400 01

Cholesterol, Total 204 High mg/dL 100-199 01

Triglycerides 335 High mg/dL 0-149 01

HDL Cholesterol 32 Low mg/dL >39 01

VLDL Cholesterol Cal 67 High mg/dL 5-40

LDL Cholesterol Calc 105 High mg/dL 0-99

T. Chol/HDL Ratio 6.4 High ratio 0.0-5.0

Please Note: 01

T. Chol/HDL Ratio

Men Women

1/2 Avg.Risk 3.4 3.3

Avg.Risk 5.0 4.4

2X Avg.Risk 9.6 7.1

3X Avg.Risk 23.4 11.0

C-Reactive Protein, Cardiac 0.70 mg/L 0.00-3.00 01

Relative Risk for Future Cardiovascular Event

Low <1.00

Average 1.00 - 3.00

High >3.00

Homocyst(e)ine 7.0 umol/L 0.0-14.5 01

**Please note reference interval change**

TSH 2.870 uIU/mL 0.450-4.500 01

Thyroxine (T4) 7.5 ug/dL 4.5-12.0 01

T3 Uptake 29 % 24-39 01

Free Thyroxine Index 2.2 1.2-4.9

Triiodothyronine (T3) 99 ng/dL 71-180 01

Triiodothyronine (T3), Free 3.0 pg/mL 2.0-4.4 01

Reverse T3, Serum A 18.9 ng/dL 9.2-24.1 02

T4,Free(Direct) 1.31 ng/dL 0.82-1.77 01

Thyroid Peroxidase (TPO) Ab <9 IU/mL 0-34 01

Thyroglobulin Antibody <1.0 IU/mL 0.0-0.9 03

Thyroglobulin Antibody measured by Beckman Coulter Methodology

Vitamin D, 25-Hydroxy 17.5 Low ng/mL 30.0-100.0 01

Vitamin D deficiency has been defined by the Institute of

Medicine and an Endocrine Society practice guideline as a

level of serum 25-OH vitamin D less than 20 ng/mL (1,2).

The Endocrine Society went on to further define vitamin D

insufficiency as a level between 21 and 29 ng/mL (2).

1. IOM (Institute of Medicine). 2010. Dietary reference

Date Issued: 06/26/20 0924 ET FINAL REPORT This document contains private and confidential health information protected by state and federal law.

If you have received this document in error, please call 303-792-2600

Page 2 of 4

1995-2020 Laboratory Corporation of America® Holdings

All Rights Reserved - Enterprise Report Version:

1.00Patient Report

Patient:  Specimen ID: 170-612-0650-0

  Control ID: HA5S9Z929A2 Date collected: 06/18/2020 0844 Local

TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB

intakes for calcium and D. Washington DC: The

National Academies Press.

2. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al.

Evaluation, treatment, and prevention of vitamin D

deficiency: an Endocrine Society clinical practice

guideline. JCEM. 2011 Jul; 96(7):1911-30.

Fibrinogen Activity 249 mg/dL 193-507 01

. 01

CBC, Platelet Ct, and Diff 01

WBC 4.7 x10E3/uL 3.4-10.8 01

RBC 6.07 High x10E6/uL 4.14-5.80 01

Hemoglobin 17.6 g/dL 13.0-17.7 01

Hematocrit 53.9 High % 37.5-51.0 01

MCV 89 fL 79-97 01

MCH 29.0 pg 26.6-33.0 01

MCHC 32.7 g/dL 31.5-35.7 01

RDW 12.2 % 11.6-15.4 01

Platelets 213 x10E3/uL 150-450 01

Neutrophils 56 % Not Estab. 01

Lymphs 32 % Not Estab. 01

Monocytes 9 % Not Estab. 01

Eos 2 % Not Estab. 01

Basos 1 % Not Estab. 01

Neutrophils (Absolute) 2.7 x10E3/uL 1.4-7.0 01

Lymphs (Absolute) 1.5 x10E3/uL 0.7-3.1 01

Monocytes(Absolute) 0.4 x10E3/uL 0.1-0.9 01

Eos (Absolute) 0.1 x10E3/uL 0.0-0.4 01

Baso (Absolute) 0.0 x10E3/uL 0.0-0.2 01

Immature Granulocytes 0 % Not Estab. 01

Immature Grans (Abs) 0.0 x10E3/uL 0.0-0.1 01

. 01

Urinalysis Gross Exam 01

Specific Gravity 1.018 1.005-1.030 01

pH 5.5 5.0-7.5 01

Urine-Color Yellow Yellow 01

Appearance Clear Clear 01

WBC Esterase Negative Negative 01

Protein Negative Negative/Trace 01

Glucose Negative Negative 01

Ketones Negative Negative 01

Occult Blood Negative Negative 01

Bilirubin Negative Negative 01

Urobilinogen,Semi-Qn 0.2 mg/dL 0.2-1.0 01

Date Issued: 06/26/20 0924 ET FINAL REPORT This document contains private and confidential health information protected by state and federal law.

If you have received this document in error, please call 303-792-2600

Page 3 of 4

1995-2020 Laboratory Corporation of America® Holdings

All Rights Reserved - Enterprise Report Version:

1.00Patient Report

Patient:  Specimen ID: 170-612-0650-0

  Control ID: HA5S9Z929A2 Date collected: 06/18/2020 0844 Local

TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB

Nitrite, Urine Negative Negative 01

Microscopic Examination 01

Microscopic not indicated and not performed.

```
